SUMMARY UCHL1 is a murine monoclonal antibody that recognises a 180-185 kD determinant on CD4 (72%) and CD8 (36%) positive T cells. This antibody is effective in formalin fixed and paraffin embedded tissues, using the immunoperoxidase method. One hundred and forty three cases of malignant lymphoma were examined. Neoplastic cells in 100% of cases of Mycosis fungoides (n = 10), 83% of cases of peripheral T cell lymphoma (n = 25), and 78% of cases of (T-ALL) T acute lymphoblastic lymphoma (n = 9) were stained by this antibody. In addition, staining was seen in 100% of cases of malignant histiocytosis of the intestine (n = 13), a condition now thought to be a T cell lymphoma. UCHL1 is a monoclonal antibody that identifies T cells in formalin fixed paraffin embedded tissues, and should prove useful for diagnosing T cell lymphomas, especially when only formalin fixed tissue is available for diagnosis.
SUMMARY UCHL1 is a murine monoclonal antibody that recognises a 180-185 kD determinant on CD4 (72%) and CD8 (36%) positive T cells. This antibody is effective in formalin fixed and paraffin embedded tissues, using the immunoperoxidase method. One hundred and forty three cases of malignant lymphoma were examined. Neoplastic cells in 100% of cases of Mycosis fungoides (n = 10), 83% of cases of peripheral T cell lymphoma (n = 25), and 78% of cases of (T-ALL) T acute lymphoblastic lymphoma (n = 9) were stained by this antibody. In addition, staining was seen in 100% of cases of malignant histiocytosis of the intestine (n = 13), a condition now thought to be a T cell lymphoma. Two cases of true histiocytic lymphoma were also positive. This antibody stained neither the neoplastic cells in a wide range of B cell lymphomas (n = 62) nor Reed-Stemnberg cells in 16 cases of Hodgkin's disease. UCHL1 also stained neoplastic cells in four cases of granulocytic sarcoma. A panel of normal tissues was similarly studied. Staining was seen in normal T cells and mucosal intraepithelial lymphocytes, macrophages, mature myeloid cells, and endometrial stromal granulocytes.
UCHL1 is a monoclonal antibody that identifies T cells in formalin fixed paraffin embedded tissues, and should prove useful for diagnosing T cell lymphomas, especially when only formalin fixed tissue is available for diagnosis.
Many monoclonal antibodies to T cell related membrane antigens have been produced. These antibodies effectively stain T cells in cryostat sections of fresh frozen tissue, cell suspensions, and cytological preparations. To date there have been no reliable T cell markers for routinely fixed wax embedded tissue. This is a serious limitation as most routine histological material arrives in fixative. Furthermore, the quality of cryostat sections is inferior to that of paraffin embedded tissue. Unlike B cell lymphomas, there is no reliable method of assessing clonality in a malignant T cell proliferation. Diagnosis in these instances rests on showing the presence of T cell specific markers on the neoplastic population of cells, a population often difficult to identify with certainty in frozen sections. The use of monoclonal antibodies effective on paraffin embedded tissue will overcome these difficulties. We describe the use of a new monoclonal antibody (UCHLl),' which recognises a T cell related membrane antigen on normal and up to 86% of neoAccepted for publication 2 January 1986 plastic T cells. Not only is this antibody an effective T cell marker in cryostat cut sections, but reliable membrane staining of T cells is seen in routinely fixed wax embedded tissue.
Material and methods

MONOCLONAL ANTIBODIES
UCHLI
This murine (IgG2a monoclonal antibody) was produced by conventional procedures using the spleen from a BALB/c mouse that had been extensively immunised with T cells from an IL-2 dependent T cell line (CAl).' SOURCE OF TISSUE Normal tissues Formalin fixed paraffin embedded normal tissues were taken from the surgical pathology files at this hospital (Table 1) . Six fetal thymuses covering gestational ages from 20 weeks to full term were taken at necropsy within 72 hours of death.
Tonsils from routine tonsillectomies were fixed in 399 Norton, Ramsay, Smith, Beverley, Isaacson were serious limitations when tissues fixed in formalins of pH < 3 1 were studied. Bouin's fixative and mercurial fixatives were wholly unsuitable at preserving the membrane antigen recognised by UCHL1. Proteolytic digestion with trypsin and the use of imidazole in the development of the peroxidase reaction both introduced unacceptably high non-specific background staining. In necropsy tissue taken within 72 hours of death the cytology was poor, but the membrane antigen was still preserved. Bone marrow trephines that had been decalcified in formic acid for 24 hours following fixation were also found to give adequate results with UCHL1.
NORMAL TISSUES Table 1 summarises the normal tissues studied and their reactivity with UCHLI. Lymphocytes in the T cell areas of normal tonsil (Fig. 1) , spleen, and normal and reactive lymph nodes were recognised by UCHLI. In thymic tissue 90% of cortical thymocytes and about 50% of medullary thymocytes were stained at all ages studied. In contrast, the large cortical thymic blasts were negative. Membrane staining in mature myeloid cells and about 20% of macrophages was a constant finding in all the tissues sampled.
Bone marrow smears were stained by the APAAP method to overcome the high concentrations of endogenous peroxidase. Cells of megakarocytic and erythroid lineages were uniformly negative. Table 2 . Some large B cell lymphomas 404 of centroblastic and immunoblastic types, however, gave diffuse cytoplasmic staining with UCHL1.
Of the B cell neoplasms, those which failed to stain with the antibody were those of true centrocytic type and cases of multiple lymphomatous polyposis. These cases are interesting because they show cross reactivity with the T cell related marker CD5, recognised by antibodies such as Leu-l.' 6 In all cases reactive T cells were stained as well as a proportion of myeloid cells.
Hodgkin's disease Tissue from 16 cases of Hodgkin's disease representing the major histological subtypes was examined (Table 3) . Reed-Sternberg cells and their mononuclear variants, as well as the L and H cells of lymphocyte predominant nodular Hodgkin's disease, were not stained by UCHL1. Cytoplasmic staining was observed in many Reed-Sternberg cells. The reactive infiltrates of T cells were positive, including the rings of T helper cells disposed around the ReedStemnberg cells.7 Reactivity with myeloid cells was also seen.
Leukaemic deposits and granulocytic sarcoma Four cases of granulocytic sarcoma were examined; two cases from the gastrointestinal tract, one from the skin, and one from lymph node. Membrane staining with UCHLI was seen in all cases. The staining was restricted to the more mature myeloid cells; these findings were similar to that seen in normal marrow. Soft tissue deposits from two cases of common acute lymphoblastic leukaemia showing a pre-B phenotype were also studied. Neither case was stained by UCHL1.
True histiocytic lymphoma (ofmonocyte or macrophage derivation) Two cases of true histiocytic lymphoma were studied. Their immunophenotype had been determined on cryostat cut sections.8 UCHLI gave weak focal membrane staining similar to that seen in reactive macrophages in normal tissues.
Malignant histiocytosis of the intestine Thirteen cases of malignant histiocytosis of the intestine were examined. All of the cases expressed membrane staining with UCHL1 (Fig. 2) . Two of the cases had shown a T cell immunophenotype determined on cryostat sections and a genetic rearrangement at the T cell receptor ,B chain locus.9
T cell lymphomas Forty three cases of T cell lymphoma were studied (Table 4) . Ten cases were of classical Mycosis funNorton, Ramsay, Smith, Beverley, Isaacson goides of the erythrodermic and plaque stages, nine were T lymphoblastic lymphomas, and the remaining 25 encompassed a wide range of T cell lymphoma phenotypes. All cases of lymphoblastic lymphoma and 16 cases of peripheral T cell lymphoma had their immunophenotype determined on cryostat cut material. The remaining five cases of peripheral T cell lymphoma and all but two cases of Mfungoides had been diagnosed on morphological grounds. Neoplastic cells in all of the cases of Mfungoides were stained by UCHL1. Staining was seen in all three cases of HTLV-l positive T cell lymphoma (Fig. 3) and seven of the nine cases of lymphoblastic lymphoma. UCHL1 stained the neoplastic cells in 18 of the 22 remaining cases of peripheral T cell lymphoma (Fig. 4) .
Discussion
The approach to lymphoproliferative disorders has been greatly influenced by the advent of immunocytochemical techniques. Numerous polyclonal and monoclonal antisera to cells of B, T, and macrophage derivation are now available. Their principle disadvantage lies in their failure to stain routinely fixed histological material reliably. Some markers of the macrophage have been described,'0 which are effective in paraffin embedded tissue, and recently the antibodies LN-1 and LN-2 have been described, which recognise B cells in B5 fixed tissues. " Antibodies to HLA-D region antigens, which are useful in the diagnosis of lymphoreticular tumours embedded in paraffin, have also been described.12 13 Using the immunogold technique'4 it is possible to achieve limited success in fixed tissues with pan T reagents effective only on frozen sections. No reliable marker of T cells in routinely processed material, however, has yet been described.
Our results show that UCHL1 is a useful marker of normal and neoplastic T cells both in cryostat sections and in formalin fixed paraffin embedded tissue. The choice of fixative is important for the preservation of the antigen. Bouin's fixative, mercuric fixatives, and highly acidic formalins are unsuitable for its use.
The UCHL1 antigen seems to be expressed fairly early in T cell ontogeny. The staining of more mature T lymphoblastic lymphomas and some T lymphobastic cell lines and the staining of common cortical thymocytes supports this observation. The T lymphoblastic lymphomas, which did not stain, showed early thymic phenotypes on frozen sections.5 UCHL1 seems to recognise a previously undetected antigen, which has been shown by immunoprecipitation to be a protein of molecular weight Recognition of normal and neoplastic T cells by monoclonal antibody (UCHLI) The most consistent finding was the expression of the CD3 and CD7 antigens in association with UCHL1. Those T cell lymphomas that did not stain with the antibody also showed poor expression of a large range of pan T and T lymphocyte subset specific antigens in frozen sections. For example, one case tested with seven T cell specific antibodies expressed only the CD2 antigen.
The staining results in malignant histiocytosis of the intestine are interesting. Recent work strongly suggests that this tumour, once thought to be of macrophage derivation, is a T cell lymphoma.9 Our results support this view. Although UCHLI staining was also seen in true histiocytic lymphomas, the staining was far weaker than that seen in T cell lymphomas and malignant histiocytosis of the intestine.
The cross reactivity of the antibody with cells of mature myeloid and macrophage lineage is also interesting. Several other monoclonal antibodies, which recognise T cell related antigens, cross react with macrophages and cells of the myeloid series.15 For diagnostic purposes this cross reactivity should present no problems in the use of UCHL1, as long as the antibody is used as part of a panel of reagents.
In conclusion, UCHL1 is a reliable marker of normal and neoplastic T cells in formalin fixed paraffin embedded tissues and should prove to be a valuable addition to the limited range of antibodies effective in fixed tissues.
